Integrative experimental and computational approach for the development of novel plasminogen activators from truncated streptokinase fragments
{{output}}
Streptokinase (SK), a widely used thrombolytic agent, activates human plasminogen, which in turn dissolves blood clots. However, its clinical application is limited because it elicits immunogenic responses in patients. The present study aims to develop novel p... ...
